EGFR

EGFR 受体酪氨酸激酶 (RTK) 家族包含四种不同的受体:EGFR(也称为 ErbB-1/HER1)、ErbB-2(neu、HER2)、ErbB-3(HER3)和 ErbB-4(HER4)。所有 EGFR 家族成员都具有模块化结构,由胞外配体结合结构域、单个疏水跨膜区和含有高度保守的酪氨酸激酶结构域的胞内部分组成。ErbB 受体酪氨酸激酶 (RTK) 家族将胞外生长因子配体的结合与胞内信号通路偶联,从而调节多种生物反应,包括增殖、分化、细胞运动和存活。十种生长因子及其 ErbB 特异性为:EGF、双调蛋白 (AR) 和 TGF 与 ErbB-1 结合; β细胞调节蛋白和表皮调节蛋白可结合 ErbB-1 和 ErbB-4;神经调节蛋白(也称为神经调节蛋白和 Neu 分化因子)NRG-1 和 NRG-2 可结合 ErbB-3 和 ErbB-4;NRG-3 和 NRG-4 可结合 ErbB-4。没有已知的配体可结合 ErbB-2。通过 ErbB 诱导的三种最典型的信号通路是 Ras-丝裂原活化蛋白激酶 (Ras-MAPK)、磷脂酰肌醇 3 激酶-蛋白激酶 B (PI3K-PKB/Akt) 和磷脂酶 C-蛋白激酶 C (PLC-PKC) 通路。

The EGFR family of receptor tyrosine kinases (RTK) comprises four distinct receptors: the EGFR (also known as ErbB-1/HER1), ErbB-2 (neu, HER2), ErbB-3 (HER3) and ErbB-4 (HER4). All EGFR family members are characterized by a modular structure consisting of an extracellular ligand-binding domain, a single hydrophobic transmembrane region, and the intracellular part harbouring the highly conserved tyrosine kinase domain. The ErbB family of receptor tyrosine kinases (RTKs) couples binding of extracellular growth factor ligands to intracellular signaling pathways regulating diverse biologic responses, including proliferation, differentiation, cell motility, and survival. Ten growth factors and their ErbB specificities are: EGF, amphiregulin (AR), and TGF bind ErbB-1; betacellulin, and epiregulin bind both ErbB-1 and ErbB-4; the neuregulins (also called heregulins and Neu differentiation factors) NRG-1 and NRG-2 bind ErbB-3 and ErbB-4; and NRG-3 and NRG-4 bind ErbB-4. No known ligand binds ErbB-2. The three best characterized signaling pathways induced through ErbBs are Ras-mitogen-activated protein kinase (Ras-MAPK), phosphatidylinositol 3 kinase-protein kinase B (PI3K-PKB/Akt), and phospholipase C-protein kinase C (PLC-PKC) pathways.

共 4种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
Anti-HER3 Antibody (Ab562)
AMT-562 antibody

Anti-HER3 Antibody (Ab562) 是一种抗 HER3 单克隆抗体,可用于合成抗体-药物偶联物 (ADC) AMT-562 (MS-U23687)。

Antagonist
99.63%
Anti-HER3 Antibody (Ab562)
HLX-22
AC101

HLX-22 是一种靶向 HER2 的人源化单克隆抗体,与 Trastuzumab (MS-U55108) 联用可诱导 HER2 过表达的乳腺癌和胃癌细胞发生凋亡 (apoptosis),并对晚期实体瘤具有强效抗肿瘤活性。

2851060-90-5
Antagonist
99.47%
HLX-22
MM-151

MM-151 是一种靶向 EGFR 的人源化 IgG1 单克隆抗体,可与 EGFR 胞外结构域 (ECD) 的多个区域结合,降低 EGFR 耐药的循环游离肿瘤 DNA 中的突变,显著抑制 EGFR 信号传导和细胞生长,并可用于耐药性癌症研究,例如结直肠癌、非小细胞肺癌和三阴性乳腺癌。

1399724-72-1
Antagonist
MM-151
NRC-2694

NRC-2694 是一种具有抗癌和抗增殖活性的表皮生长因子受体 (EGFR) 拮抗剂,也是一种含有 Alkyne 基团的点击化学试剂,可与含 Azide 基团的分子发生铜催化的叠氮-炔环加成反应 (CuAAc)。

936446-61-6
Antagonist
99.84%
NRC-2694

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础